HIGHLIGHTS
- who: Navjit Dharampal from the Section of Otolaryngology, Department of Surgery, University of Calgary, T N, Canada have published the paper: Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules, in the Journal: (JOURNAL)
- what: The aim of this study was to evaluate the cost-effectiveness of Afirma a commercially available molecular test in cytologically indeterminate thyroid nodules.
- how: Lastly the treatment algorithm utilized in the model is based on the most recent ATA Guidelines published in 2015 thereby making the model more aligned with current clinical practice and the most . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.